Clearance of Persistent Methicillin-Susceptible Staphylococcus lugdunensis Bacteremia Using Nafcillin Plus Ertapenem Combination Therapy

被引:0
|
作者
Sharma, Ishrya [1 ]
Hodges, Jacqueline [1 ]
Moonah, Shannon [1 ]
Shirley, Debbie-Ann [2 ]
机构
[1] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA
[2] Univ Virginia, Dept Pediat, Div Pediat Infect Dis, Charlottesville, VA USA
关键词
bacteremia; ertapenem; S; lugdunensis; ENDOCARDITIS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Staphylococcus lugdunensis is a coagulase-negative staphylococcus that can cause serious infection similar to Staphylococcus aureus. Limited therapeutic options are available for patients with staphylococcal bacteremia who fail to respond to standard monotherapy, particularly when source control of infection is not feasible, driving the need for improved synergistic antibiotic combinations to enhance medical management. We present the case of a 58-year-old patient with persistent S. lugdunensis bacteremia for over 1 week despite appropriate therapy with nafcillin. Blood cultures were successfully sterilized following the addition of ertapenem salvage therapy, with rapid blood culture clearance within 2 days of initiation. To our knowledge, this is the first report of using ertapenem in combination with an antistaphylococcal penicillin to specifically clear persistent S. lugdunensis bacteremia. Similar success has been reported using this combination to treat methicillin-susceptible S. aureus infections; hence, our report provides further support for the benefit of this combination for staphylococcal infections.
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
    Davie Wong
    Titus Wong
    Marc Romney
    Victor Leung
    Annals of Clinical Microbiology and Antimicrobials, 15
  • [32] The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Miller, William R.
    Seas, Carlos
    Carvajal, Lina P.
    Diaz, Lorena
    Echeverri, Aura M.
    Ferro, Carolina
    Rios, Rafael
    Porras, Paola
    Luna, Carlos
    Gotuzzo, Eduardo
    Munita, Jose M.
    Nannini, Esteban
    Carcamo, Cesar
    Reyes, Jinnethe
    Arias, Cesar A.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (06):
  • [33] Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial
    Cheng, Matthew P.
    Lawandi, Alexander
    Butler-Laporte, Guillaume
    De L'Etoile-Morel, Samuel
    Paquette, Katryn
    Lee, Todd C.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (09) : E196 - E203
  • [34] Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?
    Karchmer, Adolf W.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (01) : 107 - 109
  • [35] Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?
    Sylvain A. Lother
    Natasha Press
    Current Infectious Disease Reports, 2017, 19
  • [36] Once-Daily Treatments for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Are They Good Enough?
    Lother, Sylvain A.
    Press, Natasha
    CURRENT INFECTIOUS DISEASE REPORTS, 2017, 19 (11)
  • [37] Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia
    Sakoulas, George
    Olson, Joshua
    Yim, Juwon
    Singh, Niedita B.
    Kumaraswamy, Monika
    Quach, Diana T.
    Rybak, Michael J.
    Pogliano, Joseph
    Nizet, Victor
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6609 - 6618
  • [38] Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
    Burrelli, Corey C.
    Broadbent, Eleanor K.
    Margulis, Alice
    Snyder, Graham M.
    Gold, Howard S.
    McCoy, Christopher
    Mahoney, Monica V.
    Hirsch, Elizabeth B.
    CHEMOTHERAPY, 2018, 63 (06) : 345 - 351
  • [39] Clinical Implications of Cefazolin Inoculum Effect and β-Lactamase Type on Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Lee, Shinwon
    Kwon, Ki Tae
    Kim, Hye-In
    Chang, Hyun Ha
    Lee, Jong-Myung
    Choe, Pyoeng Gyun
    Park, Wan Beom
    Kim, Nam Joong
    Oh, Myoung-Don
    Song, Do Young
    Kim, Shin-Woo
    MICROBIAL DRUG RESISTANCE, 2014, 20 (06) : 568 - 574
  • [40] Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus
    Li, Julius
    Echevarria, Kelly L.
    Hughes, Darrel W.
    Cadena, Jose A.
    Bowling, Jason E.
    Lewis, James S., II
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5117 - 5124